Open access
Sep 2026
Assessment of the Clinical Value of Voriconazole Drug Interactions: A Real-world Disproportionality-Based Analysis
Voriconazole (VCZ) has a narrow therapeutic window and is metabolized by CYP450 enzymes, predisposing it to adverse drug events (ADEs) and drug-drug interactions (DDIs), yet its multisystem safety profile and combination-therapy characteristics in real‑world practice remain inadequately understood. To address this gap,...
Yi-Yu Feng, Tao Zhao, Jia-Min Zhu et al.
· International Journal of Cli... · 0 citations